Describe Anion Gaps

Ms. Brown is a 70-year-old woman with type 2 diabetes mellitus who has been too ill to get out of bed for 2 days. She has had a severe cough and has been unable to eat or drink during this time. On admission, her laboratory values show the following:
Serum glucose 412 mg/dL
Serum sodium (Na+) 156 mEq/L
Serum potassium (K+) 5.6 mEq/L
Serum chloride (Cl–) 115 mEq/L
Arterial blood gases (ABGs): pH 7.30; PaCO2 32 mmHg; PaO2 70 mmHg; HCO3– 20 mEq/L
Case Study 2 Questions:
Based on Ms. Brown admission’s laboratory values, could you determine what type of water and electrolyte imbalance she has? Name all of them based on the lab results and clinical presentation.
Describe the signs and symptoms of the different types of water imbalance, and describe the clinical manifestation she might exhibit with the potassium level she has.
In the specific case presented which would be the most appropriate treatment for Ms. Brown and why? Include both pharmacologic and non-pharmacologic approaches.
What do the ABGs from Ms. Brown indicate regarding her acid-base imbalance?
Based on your readings and your research define and describe Anion Gaps and their clinical significance.
describe Anion Gaps

Based on Ms. Brown’s admission laboratory values and clinical presentation, she appears to have multiple water and electrolyte imbalances:

  1. Hyperglycemia: Her serum glucose level of 412 mg/dL indicates hyperglycemia, which is an excess of glucose in the blood. This is commonly seen in uncontrolled diabetes mellitus and can lead to osmotic diuresis, causing water loss.
  2. Hypernatremia: Her serum sodium (Na+) level of 156 mEq/L is above the normal range (135-145 mEq/L), indicating hypernatremia. This condition occurs when there is a deficit of water relative to sodium, which can be caused by dehydration or excessive sodium intake.
  3. Hyperkalemia: Her serum potassium (K+) level of 5.6 mEq/L is above the normal range (3.5-5.0 mEq/L), indicating hyperkalemia. This elevated potassium level may result from factors such as impaired kidney function or acidosis.
  4. Hyperchloremia: Her serum chloride (Cl–) level of 115 mEq/L is above the normal range (98-106 mEq/L), indicating hyperchloremia, which can occur as a result of dehydration or metabolic acidosis.

Signs and symptoms of these water and electrolyte imbalances include:

  • Hyperglycemia: Excessive thirst, frequent urination, fatigue, blurred vision, and in severe cases, ketoacidosis can lead to nausea, vomiting, and altered mental status.
  • Hypernatremia: Thirst, dry mucous membranes, confusion, restlessness, and in severe cases, neurological symptoms such as seizures and coma.
  • Hyperkalemia: Weakness, muscle cramps, palpitations, and in severe cases, cardiac arrhythmias.
  • Hyperchloremia: Typically associated with other electrolyte imbalances or underlying conditions. Symptoms may include weakness and confusion.

With her elevated potassium level (5.6 mEq/L), Ms. Brown may exhibit signs such as muscle weakness, palpitations, and potential cardiac arrhythmias. Severe hyperkalemia can be life-threatening and requires immediate medical attention.

In this specific case, the most appropriate treatment for Ms. Brown would involve both pharmacologic and non-pharmacologic approaches:

  1. Hydration: Rehydration with intravenous fluids to address her hypernatremia and dehydration. Normal saline or a balanced electrolyte solution may be used.
  2. Insulin therapy: Insulin administration to lower her elevated blood glucose levels and correct the underlying cause of hyperglycemia.
  3. Correction of hyperkalemia: This may include the administration of medications like calcium gluconate, sodium bicarbonate, and/or insulin with glucose to shift potassium into cells, as well as potassium-lowering medications like diuretics or potassium binders.
  4. Addressing the underlying illness: Management of her severe cough and any other medical conditions contributing to her illness.

The ABGs from Ms. Brown indicate a primary metabolic acidosis with a pH of 7.30, a decreased bicarbonate (HCO3–) level of 20 mEq/L, and a slightly low PaCO2 of 32 mmHg. This suggests that she is in a state of metabolic acidosis, likely due to her uncontrolled diabetes mellitus and dehydration. The decreased bicarbonate reflects the presence of an excess of non-volatile acids in the body.

Anion Gap: The anion gap is calculated as follows: Anion Gap = (Na+ – [Cl– + HCO3–]). In Ms. Brown’s case, the anion gap would be (156 – [115 + 20]) = 21 mEq/L. This is an elevated anion gap, indicating that there are unmeasured anions present in her blood. An elevated anion gap is characteristic of metabolic acidosis and can be associated with conditions like diabetic ketoacidosis (DKA).

Clinical Significance of Anion Gap: The anion gap helps diagnose the underlying cause of metabolic acidosis. An elevated anion gap suggests the presence of acids like ketones or lactate, which are commonly seen in conditions such as DKA, lactic acidosis, or renal failure. Identifying the cause of metabolic acidosis is crucial for appropriate treatment and management.

In summary, Ms. Brown presents with hyperglycemia, hypernatremia, hyperkalemia, and hyperchloremia, indicating multiple water and electrolyte imbalances. Her ABGs suggest metabolic acidosis, possibly due to diabetic ketoacidosis. Treatment should focus on rehydration, insulin therapy, correction of hyperkalemia, and addressing the underlying illness. The elevated anion gap is indicative of an underlying metabolic acidosis, which requires further investigation to determine the specific cause.

Scroll to Top